Professional Presentations

Dr. George Capone represents the work of the Down Syndrome Clinic and Research Center (DSCRC) around the world and throughout the United States. Below are both international and national publications and presentations to which he is credited.

International:

  • Keynote speaker, “Healthcare for adults with Down Syndrome”. Panel discussion on “Developmental, behavioral phenotypes and maladaptive behavior in children with DS”, IV Iberoamerican Congress, Federacion Iberoamerican de Sindrome de Down. Salamanca, Spain March 18-20, 2016
  • Keynote speaker, “Common Health Conditions, impact on development and function”, Medical Roundtable speaker at Down Syndrome Research Foundation, Vancouver, B.C. October 23-24, 2015
  • Keynote speaker, ”Healthcare for all persons w/ DS”  Medical Pre-symposium speaker, Health Committee Member at 12th World Down Syndrome Congress, Down Syndrome International, Chennai, India August 16-22nd 2015
  • Delivered six presentations (Neurobehavior, Mental Health, Sleep, General Medical Conditions Across the Lifespan, Organization of Down Syndrome Clinics and the Professional Organization Down Syndrome Medical Interest Group)  at Congresso V en Sindrome de Down, Monterrey, Mexico, October 2014. Received the Cecilia Guerra Aguilasocho Award
  • Keynote speaker at (3 lectures) Down syndrome: Medical News and Research Priorities for Brain Function and Development, Down Syndrome Research Foundation, Vancouver, B.C. June 2014
  • Keynote speaker, “Addressing behavioral issues in individuals with DS”, an International Conference for Parents and Professionals. Down syndrome Ireland, Dublin, IR, November 2013
  • “Neurobehavioral conditions in children with DS”, and “Clinical trials targeting cognition and behavior in children with DS”. III Iberoamerican Congress on Down Syndrome, Federacion Iberoamerican de Sindrome de Down. Monterrey Mexico, October 2013
  • "Neurological and Behavioral Disorders of Children and Adolescents with Down Syndrome," "Neurological and Behavioral Disorders in Adults with Down Syndrome," and "Disruptive Behavior in Down Syndrome." Congreso Sindrome de Down. Monterrey, Mexico. October 2010.
  • "Down Syndrome: Characterization and Management of Neurobehavioral and Sleep Disorders" and "Dual Diagnosis: Neurobehavioral Disorders in Adolescents and Adults." Simposio Sindrome de Down, Mis amigos de syndrome de Down. San Juan, Puerto Rico. September 2009.
  • "Down Syndrome Cognitive and Neurodevelopmental Function." Fourth Congreso de Educacion Especial. Guatemala City, Guatemala. February 2008.
  • "Down Syndrome and Co-Morbid Autism." Jerome Lejuene Clinical Conference. Paris, France. November 2006.
  • "Down Syndrome: Characterization and Medical Management of Neurobehavioral Disorders." Down's Syndrome Association. Teddington, UK. October 2006.
  • "Down Syndrome: Development and Behavior" and "Down Syndrome: A Research Update." Greiningar State Diagnostic and Counseling Center. Reykjavik, Iceland. October 2006.
  • "Down Syndrome and Neurological Problems” and “Down Syndrome and Neurodevelopment." Third International Conference, John Langdon Down Foundation. Mexico City, Mexico. March 2004.
  • "Down Syndrome Phenomics: Toward a Definition of Neurobehavioral Phenotypes." Tenth International Molecular Biology of Chromosome 21 and Down Syndrome Workshop. Barcelona, (Stiges) Spain. September 2002.
  • "Down Syndrome and Autistic Spectrum Disorders." Clinical Case Conference, University of Lisbon. Lisbon, Portugal. May 2002.
  • "Rationale for Pharmacologic Strategies to Enhance Cognition in Down Syndrome." Second International Conference on Chromosome 21 and Medical Research on Down Syndrome. Barcelona, Spain. April 2001.
  • "Down Syndrome: Medical and Research Update" (Keynote). Down's Syndrome Association U.K. Annual Meeting. Berkshire, UK. October 2000.
  • "Biology of Down Syndrome: CNS Development and Neurobiology." Ninth International Molecular Biology of Chromosome 21 and Down Syndrome Workshop. Bar Harbor, ME. September 2000.

National:

  • “Functional Decline/Regression in Adolescents and Adults with Down Syndrome” DSMIG-USA annual Symposium, Phoenix, AZ June, 2015
  • “Common  Behavior Concerns in Children with Down Syndrome and Autism Spectrum Disorder” National Down Syndrome Congress Convention, Indianapolis, IN. July 2014
  • Keynote speaker, “Health care for all persons with DS” Down Syndrome International. In celebration of World Down Syndrome Day at the United Nations New York, NY, March 2014
  • “Characterizing depression and coexisting sleep disorders in adolescents and adults with DS” Gobal Down Syndrome Foundation: Research and Medical Care Roundtable, Denver, CO, July 2013
  • “Comorbidities in children with DS and their relevance for clinical trials”; “Realigning targets for clinical trials”; Moderator for “Clinical trials for cognition in DS”; International Workshop on Cognition in Down Syndrome- Molecular, Cellular and Behavioral Features and  the Promise of Pharmacotherapies Tysons Corner, VA April 2013
  • “Clinical Trials of Cognitive Pharmacology in Down Syndrome” Down syndrome Medical Interest Group USA Annual Symposium Washington, D. C. July 2012
  • “Treatment of medical and behavioral conditions associated with Down Syndrome” National Down Syndrome Congress Convention, Washington, D. C. July 2012
  • “Mental health conditions among adolescents and adults with Down syndrome” Down Syndrome Association of Atlanta Research Conference, Atlanta, GA, March 2012
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders" and "Perspectives on Mental Health and Sleep Disorders in Adolescents and Young Adults with Down Syndrome." National Down Syndrome Congress Convention. San Antonio, TX. August 2011.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders" and "Perspectives on Mental Health and Sleep Disorders in Adolescents and Young Adults with Down Syndrome." National Down Syndrome Congress Convention. Orlando, FL. July 2010.
  • "Maximizing Academic Potential: Treatment of Medical and Behavioral Conditions Associated with Down Syndrome." National Down Syndrome Society. New York, NY. May 2010.
  • "New Prenatal Tests for Down Syndrome." National Down Syndrome Congress Convention. Sacramento, CA (panel discussant). July 2009.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral and Sleep Disorders." National Down Syndrome Congress. Sacramento, CA. July 2009.
  • "Down Syndrome: Complex Needs." National Down Syndrome Congress. Boston, MA. August 2008.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders." National Down Syndrome Congress. Boston, MA. July 2008.
  • "Behavioral Disorders in Down Syndrome: Phenotypic or Not?" Spectrum of Developmental Disabilities XXX: Johns Hopkins University. Baltimore, MD. March 2008.
  • "Down Syndrome: Complex Needs." National Down Syndrome Congress. Kansas City, MO. August 2007.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders." National Down Syndrome Congress. Kansas City, MO. August 2007.
  • "Down Syndrome: Complex Needs." National Down Syndrome Congress. Atlanta, GA. July 2006.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders" and "Research Opportunities at KKI." National Down Syndrome Congress. Atlanta, GA. July 2006.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders" and "Research Opportunities at KKI." National Down Syndrome Congress. Anaheim, CA. August 2005.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders." National Down Syndrome Society Annual Conference. Chicago, IL. July 2005.
  • "Mental Health Issues in Persons with Down Syndrome." Association of University Centers on Disabilities. Bethesda, MD. November 2004.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders" and "Research Opportunities at KKI." National Down Syndrome Congress. Minneapolis, MN. August 2004.
  • "Down Syndrome: Characterization and Medication Management of Neurobehavioral Disorders." National Down Syndrome Society Annual Conference. Washington, DC. July 2004.
  • "Down Syndrome: Medication Management of Neurobehavioral Disorders" and "Research Opportunities at KKI." National Down Syndrome Congress. Philadelphia, PA. August 2003.
  • "Down Syndrome: Medication Management of Neurobehavioral Disorders." National Down Syndrome Society Annual Conference. St. Louis, MO. July 2003.
  • "Down Syndrome: Medication Management of Neurobehavioral Disorders." National Down Syndrome Society Annual Conference. Nashville, TN. July 2002.
  • "Down Syndrome and Autism." National Down Syndrome Congress Annual Conference. Washington, DC. July 2000.
  • "Current Down Syndrome Research-Piracetam" (Plenary Session) and "Down Syndrome and Autism." National Down Syndrome Society Annual Conference. Washington, DC. July 2000.

Appointments & Referrals

FIND A SPECIALIST

Publications

Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.

 

Resource Finder

 

A free resource that provides access to information and support for individuals and families living with developmental disabilities.